ORIHIME® Mesh Size Adjustment Can Improve Lower Urinary Tract Symptoms and Prevent Complications Such as Prolapse Recurrence in Patients Undergoing Transvaginal Mesh Surgery
Kenji Kuroda, Koetsu Hamamoto, Kazuki Kawamura, Ayako Masunaga, Hiroaki Kobayashi, Keiichi Ito
A
BSTRACT
Objectives:
Pelvic organ prolapse (POP), a multifactorial condition defined as the descent of the pelvic organs through the vaginal wall, often correlates with lower urinary tract symptoms (LUTS). Transvaginal mesh (TVM) surgery has a significant impact on LUTS; however, its therapeutic effects may vary depending on the type and shape of the mesh used. This study investigated the effects of mesh type used on LUTS and other surgical outcomes.
Materials and Methods:
We retrospectively evaluated 169 patients with POP who underwent TVM at our hospital. Preoperative and postoperative parameters were evaluated for the following patient groups: the Polyform™ group; those in the ORIHIME ® group treated without adjustment of mesh size (AMS) beneath the bladder, with or without wide arms, designated as AMS (−), and those in the ORIHIME ® group treated with AMS beneath the bladder with wide arms, designated as AMS (+).
Results:
Post-void residual urine volume, International Prostate Symptom Score (IPSS), Quality of Life (QOL) scores, the Overactive Bladder Symptom Score (OABSS), and International Consultation on Incontinence Questionnaire Short-Form score significantly decreased after surgery compared with the preoperative condition in all groups. However, the 60-min pad weight test showed a significant change after surgery only in the AMS (+) group. Upon comparing the preoperative and 1-year postoperative outcomes, the AMS (+) group showed significantly better outcomes in the IPSS plus QOL scores, OABSS, and the rate of prolapse recurrence than the AMS (−) and/or Polyform™ groups.
Conclusion:
AMS beneath the bladder can improve LUTS and prevent complications such as recurrence.